<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Toxformulation - Latest News</title>
<link href="https://news.prfree.org/rss/toxformulation/latest.xml"></link>
<updated>2026-07-21T23:36:10+00:00</updated>
<id>urn:uuid:383a6502-643b-c9f8-00a6-ecbced439789</id>
<entry>
<title>Competent Performance In Liposome Drug Formulation Sector – Latitude Pharma</title>
<link href="https://news.prfree.org/@toxformulation/competent-performance-in-liposome-drug-formulation-sector-latitude-pharma-3rmw7a88nmn4"></link>
<id>urn:uuid:a21d9a7a-04d8-93d4-52bc-e891b4717c1d</id>
<summary type="html"><![CDATA[Medicine manufacturing agencies will not be able to produce the drug commercially until they get proper licenses. Latitude Pharma will also offer necessary permits or licenses, after testing specific Liposome Drug Formulation.]]></summary>
<updated>2018-12-05T17:03:53+00:00</updated>
</entry>
</feed>